| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testosterone | 26 | 2022 | 2472 | 2.930 |
Why?
|
| Sex Hormone-Binding Globulin | 4 | 2022 | 550 | 1.700 |
Why?
|
| Receptors, Androgen | 11 | 2016 | 1079 | 1.510 |
Why?
|
| Dihydrotestosterone | 3 | 2022 | 195 | 1.400 |
Why?
|
| Myostatin | 5 | 2022 | 129 | 0.840 |
Why?
|
| Transcortin | 1 | 2017 | 13 | 0.590 |
Why?
|
| Muscle Strength | 3 | 2019 | 624 | 0.550 |
Why?
|
| beta Catenin | 3 | 2012 | 1039 | 0.540 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2022 | 1186 | 0.540 |
Why?
|
| Androgens | 7 | 2016 | 1285 | 0.530 |
Why?
|
| Chromatography, Liquid | 4 | 2022 | 982 | 0.510 |
Why?
|
| Follistatin | 3 | 2013 | 137 | 0.490 |
Why?
|
| Metabolism | 1 | 2015 | 193 | 0.450 |
Why?
|
| Anabolic Agents | 2 | 2013 | 256 | 0.450 |
Why?
|
| Models, Chemical | 2 | 2014 | 611 | 0.420 |
Why?
|
| Renal Dialysis | 1 | 2022 | 1795 | 0.420 |
Why?
|
| Muscle, Skeletal | 14 | 2022 | 4947 | 0.420 |
Why?
|
| Muscle Development | 4 | 2020 | 259 | 0.410 |
Why?
|
| Flutamide | 1 | 2012 | 95 | 0.380 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2011 | 61 | 0.370 |
Why?
|
| Sarcopenia | 2 | 2019 | 370 | 0.360 |
Why?
|
| Reproduction | 1 | 2015 | 646 | 0.360 |
Why?
|
| Hormone Replacement Therapy | 2 | 2014 | 751 | 0.330 |
Why?
|
| Protein Multimerization | 1 | 2014 | 982 | 0.330 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 630 | 0.300 |
Why?
|
| Keratinocytes | 1 | 2012 | 790 | 0.290 |
Why?
|
| Transforming Growth Factor beta | 3 | 2011 | 1962 | 0.280 |
Why?
|
| Androgen Antagonists | 2 | 2012 | 1409 | 0.250 |
Why?
|
| Prostate | 1 | 2013 | 1773 | 0.250 |
Why?
|
| Aging | 8 | 2020 | 8700 | 0.250 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2020 | 702 | 0.250 |
Why?
|
| Androstenedione | 1 | 2004 | 131 | 0.240 |
Why?
|
| Adipocytes | 2 | 2008 | 1187 | 0.230 |
Why?
|
| Exercise | 3 | 2019 | 5886 | 0.230 |
Why?
|
| Physical Conditioning, Animal | 2 | 2022 | 366 | 0.230 |
Why?
|
| Orchiectomy | 6 | 2015 | 463 | 0.220 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 3705 | 0.210 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2008 | 1642 | 0.180 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2020 | 37 | 0.180 |
Why?
|
| Wound Healing | 1 | 2012 | 2802 | 0.180 |
Why?
|
| Cell Differentiation | 5 | 2020 | 11512 | 0.170 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2021 | 685 | 0.170 |
Why?
|
| Carbon Isotopes | 1 | 2021 | 458 | 0.170 |
Why?
|
| Receptor Cross-Talk | 2 | 2012 | 115 | 0.170 |
Why?
|
| Software | 1 | 2014 | 4432 | 0.170 |
Why?
|
| Reference Values | 3 | 2022 | 4919 | 0.170 |
Why?
|
| Muscle Fibers, Skeletal | 3 | 2022 | 543 | 0.160 |
Why?
|
| Organ Size | 2 | 2015 | 2252 | 0.160 |
Why?
|
| Menstrual Cycle | 1 | 2022 | 539 | 0.160 |
Why?
|
| Peptides | 1 | 2011 | 4354 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 11 | 2020 | 22117 | 0.160 |
Why?
|
| Thermodynamics | 2 | 2011 | 593 | 0.160 |
Why?
|
| Hypogonadism | 1 | 2004 | 798 | 0.150 |
Why?
|
| Reference Standards | 1 | 2022 | 1003 | 0.150 |
Why?
|
| Mice | 19 | 2020 | 81368 | 0.150 |
Why?
|
| Skin | 1 | 2012 | 4472 | 0.150 |
Why?
|
| Regeneration | 2 | 2020 | 1505 | 0.150 |
Why?
|
| Lipolysis | 2 | 2009 | 211 | 0.150 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 437 | 0.150 |
Why?
|
| Cell Proliferation | 3 | 2012 | 10429 | 0.140 |
Why?
|
| Animals | 26 | 2022 | 168202 | 0.140 |
Why?
|
| Kinetics | 3 | 2011 | 6370 | 0.140 |
Why?
|
| Ligands | 3 | 2009 | 3268 | 0.140 |
Why?
|
| Testis | 1 | 2019 | 792 | 0.130 |
Why?
|
| Finasteride | 1 | 2016 | 86 | 0.130 |
Why?
|
| Carotid Arteries | 1 | 2020 | 941 | 0.130 |
Why?
|
| Adipogenesis | 2 | 2008 | 366 | 0.120 |
Why?
|
| Male | 31 | 2022 | 360402 | 0.120 |
Why?
|
| Estrous Cycle | 1 | 2015 | 65 | 0.120 |
Why?
|
| Erythrocyte Deformability | 1 | 2015 | 55 | 0.120 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 2016 | 112 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2015 | 110 | 0.120 |
Why?
|
| Body Weight | 3 | 2015 | 4615 | 0.120 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2016 | 192 | 0.120 |
Why?
|
| Blood Viscosity | 1 | 2015 | 124 | 0.120 |
Why?
|
| Eflornithine | 1 | 2013 | 31 | 0.110 |
Why?
|
| Ornithine Decarboxylase | 1 | 2013 | 63 | 0.110 |
Why?
|
| Joints | 1 | 2015 | 322 | 0.110 |
Why?
|
| Satellite Cells, Skeletal Muscle | 2 | 2012 | 126 | 0.110 |
Why?
|
| Allosteric Regulation | 1 | 2014 | 427 | 0.110 |
Why?
|
| Signal Transduction | 8 | 2020 | 23415 | 0.110 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2015 | 726 | 0.110 |
Why?
|
| Cachexia | 1 | 2014 | 202 | 0.110 |
Why?
|
| Sequence Analysis, Protein | 1 | 2014 | 261 | 0.100 |
Why?
|
| Luteinizing Hormone | 1 | 2015 | 820 | 0.100 |
Why?
|
| Protein Conformation | 2 | 2011 | 3965 | 0.100 |
Why?
|
| Alopecia | 1 | 2016 | 412 | 0.100 |
Why?
|
| Estradiol | 2 | 2018 | 1937 | 0.100 |
Why?
|
| Databases, Protein | 1 | 2014 | 387 | 0.100 |
Why?
|
| Humans | 34 | 2022 | 760740 | 0.100 |
Why?
|
| Mitochondria, Muscle | 1 | 2012 | 172 | 0.100 |
Why?
|
| Muscle Weakness | 1 | 2014 | 412 | 0.100 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 927 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2013 | 597 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2022 | 1582 | 0.090 |
Why?
|
| TCF Transcription Factors | 2 | 2008 | 138 | 0.090 |
Why?
|
| Ovary | 1 | 2015 | 959 | 0.090 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2013 | 352 | 0.090 |
Why?
|
| Consensus Sequence | 1 | 2011 | 364 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 3769 | 0.090 |
Why?
|
| Ion Channels | 1 | 2015 | 1039 | 0.090 |
Why?
|
| Rectal Neoplasms | 1 | 2019 | 1156 | 0.090 |
Why?
|
| Menopause | 1 | 2018 | 1645 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4569 | 0.090 |
Why?
|
| Area Under Curve | 1 | 2014 | 1635 | 0.080 |
Why?
|
| Anilino Naphthalenesulfonates | 1 | 2009 | 16 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2015 | 2669 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2014 | 1200 | 0.080 |
Why?
|
| Apolipoprotein A-I | 1 | 2011 | 299 | 0.080 |
Why?
|
| beta-Cyclodextrins | 1 | 2009 | 70 | 0.080 |
Why?
|
| Administration, Cutaneous | 1 | 2012 | 712 | 0.080 |
Why?
|
| Doxycycline | 1 | 2011 | 344 | 0.080 |
Why?
|
| Pressure | 2 | 2011 | 1150 | 0.080 |
Why?
|
| Calorimetry | 1 | 2009 | 129 | 0.080 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 974 | 0.080 |
Why?
|
| Frail Elderly | 1 | 2014 | 765 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2014 | 6233 | 0.080 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2011 | 420 | 0.080 |
Why?
|
| Growth Hormone | 1 | 2010 | 569 | 0.080 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2020 | 1533 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 705 | 0.080 |
Why?
|
| Solvents | 1 | 2009 | 294 | 0.070 |
Why?
|
| Cells, Cultured | 5 | 2011 | 18937 | 0.070 |
Why?
|
| Estrogens | 1 | 2014 | 1521 | 0.070 |
Why?
|
| Ritonavir | 1 | 2009 | 329 | 0.070 |
Why?
|
| Smad3 Protein | 1 | 2008 | 166 | 0.070 |
Why?
|
| Body Composition | 4 | 2019 | 2426 | 0.070 |
Why?
|
| Lipid Bilayers | 1 | 2009 | 383 | 0.070 |
Why?
|
| Phospholipids | 1 | 2011 | 787 | 0.070 |
Why?
|
| Erythrocytes | 2 | 2015 | 2410 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 1320 | 0.070 |
Why?
|
| HIV Protease Inhibitors | 1 | 2009 | 432 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 8516 | 0.070 |
Why?
|
| HIV Wasting Syndrome | 1 | 2007 | 99 | 0.070 |
Why?
|
| Receptors, LDL | 1 | 2009 | 488 | 0.070 |
Why?
|
| Epididymis | 1 | 2008 | 227 | 0.070 |
Why?
|
| Drug Design | 2 | 2009 | 1045 | 0.070 |
Why?
|
| Lipoproteins, HDL | 1 | 2011 | 675 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2013 | 9526 | 0.070 |
Why?
|
| Amyloid | 1 | 2011 | 841 | 0.070 |
Why?
|
| ROC Curve | 1 | 2014 | 3575 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 318 | 0.070 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 1392 | 0.060 |
Why?
|
| Endocrine System Diseases | 1 | 2008 | 249 | 0.060 |
Why?
|
| Hepatocytes | 1 | 2013 | 1231 | 0.060 |
Why?
|
| Autophagy | 1 | 2013 | 1327 | 0.060 |
Why?
|
| Adipose Tissue | 2 | 2015 | 3310 | 0.060 |
Why?
|
| Rats | 4 | 2022 | 23716 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3776 | 0.060 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 1096 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2022 | 12942 | 0.060 |
Why?
|
| Tyrosine | 1 | 2009 | 1440 | 0.060 |
Why?
|
| Amyloidosis | 1 | 2011 | 815 | 0.060 |
Why?
|
| Hot Temperature | 1 | 2011 | 1438 | 0.060 |
Why?
|
| Iron | 1 | 2013 | 1790 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3606 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 6520 | 0.060 |
Why?
|
| Linear Models | 1 | 2014 | 5866 | 0.060 |
Why?
|
| Female | 13 | 2022 | 392203 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2008 | 718 | 0.060 |
Why?
|
| Pyrazines | 1 | 2009 | 1202 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2009 | 3074 | 0.050 |
Why?
|
| Adult | 11 | 2022 | 220995 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2010 | 3419 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2004 | 1085 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2012 | 2160 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 1932 | 0.050 |
Why?
|
| Protein Transport | 1 | 2008 | 1966 | 0.050 |
Why?
|
| Time Factors | 3 | 2015 | 39908 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2008 | 2894 | 0.050 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2022 | 71 | 0.050 |
Why?
|
| Temperature | 1 | 2009 | 2224 | 0.050 |
Why?
|
| Binding Sites | 1 | 2011 | 6051 | 0.050 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 11874 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 3793 | 0.050 |
Why?
|
| Protein Binding | 2 | 2011 | 9345 | 0.050 |
Why?
|
| Aged | 6 | 2022 | 169092 | 0.050 |
Why?
|
| Smad Proteins | 2 | 2013 | 156 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2009 | 1808 | 0.050 |
Why?
|
| Middle Aged | 8 | 2022 | 220603 | 0.050 |
Why?
|
| Growth Differentiation Factors | 1 | 2022 | 100 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2011 | 5433 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2022 | 54364 | 0.040 |
Why?
|
| Myosin Heavy Chains | 2 | 2012 | 404 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 2409 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 4745 | 0.040 |
Why?
|
| Prevotella | 1 | 2019 | 80 | 0.040 |
Why?
|
| Bacteroidetes | 1 | 2019 | 83 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 3077 | 0.040 |
Why?
|
| Motor Activity | 3 | 2015 | 2714 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 4764 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 58919 | 0.040 |
Why?
|
| Sepsis | 1 | 2012 | 2585 | 0.040 |
Why?
|
| Prognosis | 2 | 2020 | 29601 | 0.040 |
Why?
|
| Young Adult | 2 | 2022 | 59191 | 0.040 |
Why?
|
| Cytokines | 1 | 2013 | 7373 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 10203 | 0.040 |
Why?
|
| Estrone | 1 | 2018 | 234 | 0.040 |
Why?
|
| Liver | 1 | 2013 | 7512 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2013 | 841 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2019 | 15609 | 0.030 |
Why?
|
| Pluripotent Stem Cells | 1 | 2003 | 796 | 0.030 |
Why?
|
| Brachial Artery | 1 | 2018 | 366 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15829 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 4408 | 0.030 |
Why?
|
| Cell Line | 3 | 2020 | 15577 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 587 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2018 | 1496 | 0.030 |
Why?
|
| Vasodilation | 1 | 2018 | 962 | 0.030 |
Why?
|
| Cathepsin L | 1 | 2013 | 69 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2015 | 560 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2009 | 3400 | 0.030 |
Why?
|
| Algorithms | 1 | 2014 | 14024 | 0.030 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2016 | 361 | 0.030 |
Why?
|
| Mice, Knockout | 3 | 2015 | 14388 | 0.030 |
Why?
|
| Feces | 1 | 2019 | 1490 | 0.030 |
Why?
|
| Cobra Cardiotoxin Proteins | 1 | 2012 | 6 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15498 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 2019 | 2897 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18220 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2013 | 418 | 0.020 |
Why?
|
| PAX7 Transcription Factor | 1 | 2011 | 55 | 0.020 |
Why?
|
| Actomyosin | 1 | 2012 | 109 | 0.020 |
Why?
|
| Bone Remodeling | 1 | 2015 | 581 | 0.020 |
Why?
|
| Transferrin | 1 | 2013 | 283 | 0.020 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2012 | 122 | 0.020 |
Why?
|
| Mifepristone | 1 | 2012 | 151 | 0.020 |
Why?
|
| Gene Expression | 2 | 2016 | 7569 | 0.020 |
Why?
|
| Immunohistochemistry | 3 | 2011 | 11069 | 0.020 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2011 | 100 | 0.020 |
Why?
|
| K562 Cells | 1 | 2013 | 641 | 0.020 |
Why?
|
| Tendons | 1 | 2015 | 558 | 0.020 |
Why?
|
| Protein Unfolding | 1 | 2011 | 56 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 9417 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 2011 | 242 | 0.020 |
Why?
|
| Adsorption | 1 | 2011 | 197 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2006 | 9310 | 0.020 |
Why?
|
| Hypophysectomy | 1 | 2010 | 114 | 0.020 |
Why?
|
| Muscles | 1 | 2015 | 1573 | 0.020 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2012 | 305 | 0.020 |
Why?
|
| Obesity | 1 | 2013 | 12934 | 0.020 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2011 | 285 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8165 | 0.020 |
Why?
|
| Extremities | 1 | 2015 | 867 | 0.020 |
Why?
|
| Eicosanoic Acids | 1 | 2009 | 15 | 0.020 |
Why?
|
| Quality Control | 1 | 2012 | 831 | 0.020 |
Why?
|
| Hand Strength | 1 | 2012 | 456 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 695 | 0.020 |
Why?
|
| Postmenopause | 1 | 2018 | 2511 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 2392 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 12143 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2011 | 8311 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2015 | 1270 | 0.020 |
Why?
|
| Gastric Mucosa | 1 | 2011 | 603 | 0.020 |
Why?
|
| Erythropoietin | 1 | 2013 | 719 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 380 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 1646 | 0.020 |
Why?
|
| Surface Properties | 1 | 2011 | 1162 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 2009 | 405 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2014 | 64572 | 0.020 |
Why?
|
| Diffusion | 1 | 2009 | 814 | 0.020 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2008 | 152 | 0.020 |
Why?
|
| Adrenoleukodystrophy | 1 | 2009 | 143 | 0.020 |
Why?
|
| Liposomes | 1 | 2011 | 784 | 0.020 |
Why?
|
| Plaque, Amyloid | 1 | 2011 | 760 | 0.020 |
Why?
|
| Stomach | 1 | 2011 | 696 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 2011 | 748 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2013 | 1524 | 0.020 |
Why?
|
| Spleen | 1 | 2013 | 2286 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 7583 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 433 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 1614 | 0.020 |
Why?
|
| Respiration | 1 | 2012 | 1656 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 3591 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2022 | 4810 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 2089 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2008 | 484 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2008 | 908 | 0.020 |
Why?
|
| Immunoassay | 1 | 2008 | 744 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 11118 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 2057 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 26065 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2011 | 5034 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2011 | 4010 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2011 | 4117 | 0.010 |
Why?
|
| Hospitalization | 1 | 2022 | 10708 | 0.010 |
Why?
|
| Stem Cells | 2 | 2007 | 3514 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8652 | 0.010 |
Why?
|
| Risk Factors | 2 | 2019 | 74128 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 1901 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2006 | 1964 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2009 | 1894 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 14649 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2015 | 12759 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2008 | 2916 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2009 | 3680 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 2829 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 4433 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 1624 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39062 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2011 | 3550 | 0.010 |
Why?
|
| Lipids | 1 | 2009 | 3332 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2003 | 1152 | 0.010 |
Why?
|
| Glucose | 1 | 2009 | 4345 | 0.010 |
Why?
|
| Weight Loss | 1 | 2007 | 2682 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 7995 | 0.010 |
Why?
|
| Biopsy | 1 | 2007 | 6763 | 0.010 |
Why?
|
| Insulin | 1 | 2009 | 6593 | 0.010 |
Why?
|
| Age Factors | 1 | 2011 | 18381 | 0.010 |
Why?
|
| Decision Making | 1 | 2008 | 3919 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 9461 | 0.010 |
Why?
|
| Inflammation | 1 | 2013 | 10759 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 7403 | 0.010 |
Why?
|
| United States | 1 | 2020 | 72292 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 36401 | 0.000 |
Why?
|
| Child | 2 | 2008 | 80089 | 0.000 |
Why?
|
| Adolescent | 2 | 2007 | 88247 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2003 | 42193 | 0.000 |
Why?
|